- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Guardian Pharmacy Services, Inc.(GRDN)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for GRDN
11/13/2026: GRDN (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Guardian Pharmacy Services, Inc. is a specialty healthcare stock that provides technology-enabled pharmacy services and medication management to long-term care facilities. The company benefits from a decentralized partnership model, proprietary software tools, and robust secular demand driven by an aging population. Its primary investment story centers on organic resident growth combined with disciplined regional acquisitions that expand operating scale. However, key risks include competitive pressures from healthcare goliaths and vulnerability to federal drug pricing regulations. The stock suits growth-oriented investors looking for exposure to senior care, with ongoing monitoring required around regulatory changes and M&A integration execution.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company delivers steady expansion in resident counts and revenue driven by secular aging trends. |
| Momentum investor | Strong fit while signal remains positive | Positive earnings updates and upwardly revised full-year guidance support favorable near-term stock momentum. |
| Value investor | Mixed fit | Valuation multiples reflect strong growth expectations, balancing against a premium price relative to traditional value benchmarks. |
| Dividend investor | Weak fit | Guardian prioritizes reinvesting capital into business expansion rather than paying significant dividends. |
| Low-risk investor | Mixed fit | While the business provides essential healthcare services with low debt, post-IPO volatility and regulatory risks introduce moderate uncertainty. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | As a relatively recent public equity, the stock can experience notable price fluctuations based on quarterly execution. |
| Valuation risk | Medium | Growth expectations are priced into the shares, leaving little room for operational missteps. |
| Competition risk (CVS Omnicare / BrightSpring PharMerica) | High | The company competes against well-resourced healthcare giants with massive purchasing and distribution networks. |
| Business quality | Strong | Guardian operates a specialized, high-retention pharmacy model backed by solid cash flows and clean credit metrics. |
| Dividend income | Low / none | Income-focused investors will find minimal dividend yield as capital is retained for growth. |
| Execution risk | Medium | Successful growth relies heavily on executing local pharmacy integrations and maintaining strict regulatory compliance. |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.14B USD | Price to earnings Ratio 42.32 | 1Y Target Price 50.14 |
Price to earnings Ratio 42.32 | 1Y Target Price 50.14 | ||
Volume (30-day avg) 480.1K shares | Beta 0.06 | 52 Weeks Range 26.34 - 50.59 | Updated Date 11/15/2026 |
52 Weeks Range 26.34 - 50.59 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.17 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Care Facilities
- BUY participation
- 88.9%
- Active BUY / eligible
- 8 / 9
- 30-Day BUY Count Change
- +6
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit 5% | Avg. Invested days 33 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Long-Term Care Pharmacy Dispensing | Dispensing prescription medications, customized multi-dose packaging, and clinical consulting services to residents in assisted living, behavioral health, and skilled nursing facilities. | This is the core revenue engine, generating recurring cash flow by supplying daily medications to vulnerable resident populations. |
| Technology & Administrative Services | Proprietary software tools like Guardian Compass that assist facilities with medication tracking, billing support, and regulatory compliance. | Adds value for care facility clients, increasing customer retention and embedding Guardian deeply into facility workflows. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2026-11-05 | When After Market | Estimate 0.28 | Actual 0.3 |
Profitability
Profit Margin 5.13% | Operating Margin (TTM) 6.47% |
Management Effectiveness
Return on Assets (TTM) 13.37% | Return on Equity (TTM) 32.01% |
Valuation
Trailing PE 42.32 | Forward PE 33.22 | Enterprise Value 3.05B | Price to Sales(TTM) 2.15 |
Enterprise Value 3.05B | Price to Sales(TTM) 2.15 | ||
Enterprise Value to Revenue 2.1 | Enterprise Value to EBITDA 23.62 | Shares Outstanding 63.32M | Shares Floating 35.90M |
Shares Outstanding 63.32M | Shares Floating 35.90M | ||
Percent Insiders 45.3 | Percent Institutions 48.97 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

